Related references
Note: Only part of the references are listed.Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
Mohammed B. Allaw et al.
ONCOLOGY (2022)
Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers
Sonja Levy et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues
Roberta Elisa Rossi et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis
Klaas Van den Heede et al.
BRITISH JOURNAL OF SURGERY (2022)
177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
Jonathan R. Strosberg et al.
LANCET ONCOLOGY (2021)
Present and future of immunotherapy in Neuroendocrine Tumors
Manuela Albertelli et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y
M. Pavel et al.
ANNALS OF ONCOLOGY (2020)
Small Bowel Neuroendocrine Tumors
Catherine G. Tran et al.
CURRENT PROBLEMS IN SURGERY (2020)
Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit
James R. Barrett et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours
Aldo Scarpa
ANNALES D ENDOCRINOLOGIE (2019)
Management of Advanced Small Bowel Cancer
Alberto Puccini et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms
S. Partelli et al.
BRITISH JOURNAL OF SURGERY (2017)
Endoscopic techniques to detect small-bowel neuroendocrine tumors: A literature review
Roberta Elisa Rossi et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
Christian Fottner et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery
Sophie Lardiere-Deguelte et al.
NEUROENDOCRINOLOGY (2016)
68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
Stephen A. Deppen et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
Exploring the Rising Incidence of Neuroendocrine Tumors: A Population-Based Analysis of Epidemiology, Metastatic Presentation, and Outcomes
Julie Hallet et al.
CANCER (2015)
Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling et al.
LANCET ONCOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
Mohid S. Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
Irvin M. Modlin et al.
PLOS ONE (2013)
Neuroendocrine tumours of the small intestine
Jonathan Strosberg
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Systemic Therapy for Advanced Carcinoid Tumors: Where Do We Go From Here?
A. Scott Paulson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Liver Transplantation for the Treatment of Liver Metastases From Neuroendocrine Tumors An Analysis of the UNOS Database
Roberto Gedaly et al.
ARCHIVES OF SURGERY (2011)
CT-Enterography May Identify Small Bowel Tumors Not Detected by Capsule Endoscopy: Eight Years Experience at Mayo Clinic Rochester
Fayaz A. Hakim et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E. Pavel et al.
LANCET (2011)
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
R. Garcia-Carbonero et al.
ANNALS OF ONCOLOGY (2010)
Small Bowel Cancer in the United States Changes in Epidemiology, Treatment, and Survival Over the Lost 20 Years
Karl Y. Bilimoria et al.
ANNALS OF SURGERY (2009)
Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation
Thomas J. Vogl et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?
Vincenzo Mazzaferro et al.
JOURNAL OF HEPATOLOGY (2007)
A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: The rapid pace of no progress
Irvin M. Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Large-volume liver metastases from neuroendocrine tumors:: Hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy
MKG McStay et al.
RADIOLOGY (2005)
Share Paper
